Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metabolic-associated Fatty Liver Disease”

233 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 233 results

Testing effectiveness (Phase 2)Study completedNCT06342947
What this trial is testing

ALG-055009 in Non-cirrhotic Adults With MASH (HERALD)

Who this might be right for
NASHMASHMetabolic Dysfunction-Associated Steatohepatitis+1 more
Aligos Therapeutics 102
Large-scale testing (Phase 3)Active Not RecruitingNCT06161571
What this trial is testing

A Study Evaluating Efruxifermin in Subjects With Non-invasively Diagnosed Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Nonalcoholic Fatty Liver Disease (NAFLD)/Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

Who this might be right for
NASH/MASHNAFLD/MASLD
Akero Therapeutics, Inc 700
Not applicableNot Yet RecruitingNCT07530419
What this trial is testing

Samsung S-Viscosity vs Canon Dispersion Slope in Steatotic Liver Disease (SAVID-SLD)

Who this might be right for
Metabolic Dysfunction-Associated Steatotic Liver DiseaseFatty LiverLiver Fibrosis
Seoul National University Hospital 95
Not applicableActive Not RecruitingNCT06315361
What this trial is testing

DIAbetes and NAFLD

Who this might be right for
NAFLDDiabetesNASH+3 more
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 600
Not applicableNot Yet RecruitingNCT07373769
What this trial is testing

Ultrasound Liver Imaging for Classification of Metabolic Dysfunction-associated Steatotic Liver Disease

Who this might be right for
Metabolic Dysfunction-Associated Steatotic Liver Disease
University of British Columbia 145
Not applicableUnknownNCT06135467
What this trial is testing

Association Betweenq MAFLD ( Metabolic Associated Fatty Liver Disease) and Chronic Kidney Disease

Who this might be right for
Mafld in Ckd Patients
Assiut University 150
Not applicableLooking for participantsNCT07330830
What this trial is testing

Study of PNPLA3 Genetic Polymorphisms in Patients With Non-Alcoholic Fatty Liver Disease in an Ultramarine Population (AdipoDROMExpo)

Who this might be right for
MASLD/MASH (Metabolic Dysfunction-Associated Steatotic Liver Disease / Metabolic Dysfunction-Associated Steatohepatitis)
Centre Hospitalier Universitaire de la Guadeloupe 600
Post-approval studies (Phase 4)Looking for participantsNCT07272343
What this trial is testing

The Impact of Semaglutide Compared to Energy Restriction on Type 2 Diabetes

Who this might be right for
Type 2 Diabetes Mellitus (T2DM)SemaglutideCaloric Restriction
Second Affiliated Hospital of Nanchang University 100
Not applicableLooking for participantsNCT07270601
What this trial is testing

Development of a Quantifiable Ultrasound Biomarker for Hepatic Steatosis

Who this might be right for
MASLD - Metabolic Dysfunction-Associated Steatotic Liver DiseaseNAFLD - Non-Alcoholic Fatty Liver Disease
ContextVision AB 110
Not applicableLooking for participantsNCT07149571
What this trial is testing

To Explore the Value of New MR Technology in Non-invasive Quantitative Assessment of Systemic Metabolism, Disease Status and Prognosis in Patients With Metabolic-Associated Fatty Liver Disease

Who this might be right for
Nonalcoholic Fatty Liver DiseaseMetabolic-associated Fatty Liver Disease
Tongji Hospital 500
Not applicableStudy completedNCT03986684
What this trial is testing

Molecules Associated With the Presence and Severity of Nonalcoholic Fatty Liver Disease

Who this might be right for
Nonalcoholic Fatty LiverMetabolic Syndrome
Hippocration General Hospital 32
Not applicableNot Yet RecruitingNCT07334639
What this trial is testing

Metabolic Changes Associated With Weight Gain After Treatment of Achalasia

Who this might be right for
Achalasia, Esophageal
Assaf-Harofeh Medical Center 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT07024212
What this trial is testing

Phase II Study Evaluating the Efficacy and Safety of DR10624 Injection in MASLD and MetALD Subjects

Who this might be right for
MASLD
Zhejiang Doer Biologics Co., Ltd. 110
Not applicableStudy completedNCT05764811
What this trial is testing

SGLT-2 Inhibitor Effects on Cardiac and Hepatic Metabolic Profiles for the Diabetes Patients Combined With Obesity

Who this might be right for
Fatty Liver Disease
National Cheng-Kung University Hospital 40
Not applicableNot Yet RecruitingNCT07053709
What this trial is testing

Screening for Hyperuricemia in Patients With Metabolic Associated Fatty Liver Disease (MAFLD)

Who this might be right for
Hyperuricemia and MAFLD
Assiut University 200
Not applicableLooking for participantsNCT05597709
What this trial is testing

Prevalence of MAFLD in Patients With Type 2 Diabetes in Jiangsu Province of China

Who this might be right for
Type 2 Diabetes Mellitus in RemissionMetabolic Associated Fatty Liver Disease
Wuxi Hisky Medical Technology Co Ltd 2,900
Not applicableUnknownNCT05913986
What this trial is testing

Supplementation With Alpha-lipoic Acid and Silybum Marianum(LUDLEV®) for the Improvement of Fatty Liver Disease

Who this might be right for
Metabolic Associated Fatty Liver Disease
Saluz Investigación S. C. 50
Not applicableLooking for participantsNCT06939569
What this trial is testing

An Observational Study of Inflammatory Bowel Disease (IBD) Patients With Non-alcoholic Fatty Liver Disease (NAFLD)

Who this might be right for
Inflammatory Bowel Disease (IBD)Metabolic Dysfunction Associated Fatty Liver Disease
Shanghai East Hospital 337
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07193927
What this trial is testing

Investigation of the Efficacy of a Probiotic Mixture in Moderate Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A Mechanistic Trial

Who this might be right for
MASLD - Metabolic Dysfunction-Associated Steatotic Liver DiseaseFatty Liver Disease, NonalcoholicOverweight (BMI > 25)
AB Biotics, SA 60
Not applicableUnknownNCT04861012
What this trial is testing

Screening for Metabolic Dysfunction Associated Fatty Liver Disease (MAFLD) at Al-Rajhy Hospital Nutrition Clinic. Assiut, Egypt

Who this might be right for
Steatohepatitis, Nonalcoholic
Assiut University 360
Load More Results